Back to Search
NALINI JANAKIRAMAN, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1730257270Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
043705(MI)
Research & Publications (14)
Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant.
PMID 19536846·Am J Hematol·2009
3-trial
Outcomes after auto-SCT in African Americans with multiple myeloma.
PMID 19139731·Bone Marrow Transplant·2009
8-other
Early relapses do not impact survival after autologous stem cell transplantation in African Americans with multiple myeloma.
PMID 17401394·Bone Marrow Transplant·2007
8-other
Phase II trial of idiotype vaccination in previously treated patients with indolent non-Hodgkin's lymphoma resulting in durable clinical responses.
PMID 16754937·J Clin Oncol·2006
3-trial
Hematologic malignancies with primary retroperitoneal presentation: clinicopathologic study of 32 cases.
PMID 15859638·Arch Pathol Lab Med·2005
8-other
Unusual presentations of hematologic malignancies: CASE 2. Precursor B-cell lymphoblastic lymphoma presenting as spinal cord compression.
PMID 15051782·J Clin Oncol·2004
5-case
Curcumin (diferuloyl-methane) enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in LNCaP prostate cancer cells.
PMID 12533677·Mol Cancer Ther·2003
8-other
Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery.
PMID 12196642·Neurology·2002
7-preclinical
Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes.
PMID 12097696·J Nutr·2002
7-preclinical
Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production.
PMID 11705464·Biochem Pharmacol·2001
7-preclinical
Therapy-related myelodysplastic syndrome (t-MDS) in a patient with anaplastic astrocytoma: successful treatment with allogeneic bone marrow transplant.
PMID 11678432·J Neurooncol·2001
5-case
IL-12 gene therapy of leukemia with hematopoietic progenitor cells without the toxicity of systemic IL-12 treatment.
PMID 11161974·Clin Immunol·2001
7-preclinical
Interleukin-12 (IL-12) gene therapy of leukemia: immune and anti-leukemic effects of IL-12-transduced hematopoietic progenitor cells.
PMID 10917209·Cancer Gene Ther·2000
7-preclinical
Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging.
PMID 10734298·Bone Marrow Transplant·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- HENRY FORD HEALTH SYSTEM, 2799 WEST GRAND BOULEVARD
DETROIT, MI 48202 - Phone
- (313) 916-2436
Quick Facts
- NPI
- 1730257270
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 14
Are you this provider?
Claim Your Profile